Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
13,108
Views
23
CrossRef citations to date
0
Altmetric
COVID-19

Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis

William V. Padulaa Department of Pharmaceutical & Health Economics, School of Pharmacy, University of Southern California, Los Angeles, CA, USA;b The Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, USA;c Department of Acute & Chronic Care, Johns Hopkins School of Nursing, Baltimore, MD, USA;d Monument Analytics, Baltimore, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1161-6954
ORCID Icon,
Shreena Malaviyad Monument Analytics, Baltimore, MD, USA;e Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
,
Natalie M. Reidd Monument Analytics, Baltimore, MD, USA
,
Benjamin G. Cohend Monument Analytics, Baltimore, MD, USA
,
Francine Chingcuancod Monument Analytics, Baltimore, MD, USA
,
Jeromie Ballreichd Monument Analytics, Baltimore, MD, USA;e Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;f Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
,
Jonothan Tierced Monument Analytics, Baltimore, MD, USA;f Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;g Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
&
G. Caleb Alexanderd Monument Analytics, Baltimore, MD, USA;f Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;g Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;h Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, MD, USA
 show all
Pages 1060-1069 | Received 22 Sep 2020, Accepted 05 Aug 2021, Published online: 31 Aug 2021

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, Mary M. Moran, Timothy L. Wiemken, Alejandro Cane, Solène de Boisvilliers, Jingyan Yang, Shailja Vaghela & Julie Roiz. (2022) Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. Journal of Medical Economics 25:1, pages 605-617.
Read now
Scott Gibson, Rhodri Saunders, Nathan Stasko, Cherrishe-Brown Bickerstaff, John Oakley, Mark Osterman, Rafael Torrejon Torres, Jonathan K. Kish, Bruce A. Feinberg & David Emerson. (2022) Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19. Journal of Medical Economics 25:1, pages 503-514.
Read now

Articles from other publishers (21)

Augustovski Federico, Bardach Ariel, Santoro Adrián, Rodriguez-Cairoli Federico, López-Osornio Alejandro, Argento Fernando, Havela Maissa, Blumenfeld Alejandro, Ballivian Jamile, Solioz Germán, Capula Analía, López Analía, Cejas Cintia, Savedoff William, Palacios Alfredo, Rubinstein Adolfo & Pichon-Riviere Andrés. (2023) Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Seoki Lee, Banghui Liu, SoYeon Jung & Bora Kim. (2023) The effect of vaccination during the COVID-19 for the restaurant industry. International Journal of Hospitality Management 110, pages 103451.
Crossref
Reyhane Izadi, Nahid Hatam, Fatemeh Baberi, Setareh Yousefzadeh & Abdosaleh Jafari. (2023) Economic evaluation of strategies against coronavirus: a systematic review. Health Economics Review 13:1.
Crossref
Huixuan Zhou, Ningxin Ding, Xueyan Han, Hanyue Zhang, Zeting Liu, Xiao Jia, Jingjing Yu & Wei Zhang. (2023) Cost-effectiveness analysis of vaccination against COVID-19 in China. Frontiers in Public Health 11.
Crossref
Giuseppe Santoli, Mario Cesare Nurchis, Giovanna Elisa Calabrò & Gianfranco Damiani. (2023) Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence. Vaccines 11:2, pages 347.
Crossref
Conghui Liu. (2023) Economic Evaluation of Covid-19 Vaccines: A Literature Review. Highlights in Business, Economics and Management 3, pages 197-203.
Crossref
Auliasari Meita Utami, Farida Rendrayani, Qisty Aulia Khoiry, Dita Noviyanti, Auliya A Suwantika, Maarten J Postma & Neily Zakiyah. (2023) Economic evaluation of COVID-19 vaccination: A systematic review. Journal of Global Health 13.
Crossref
Konstantinos Miliordos, Theodoros Giannouchos, Evangelia Steletou, Georgios Sanidas, Aglaia Karkania, Aggeliki Vervenioti, Gabriel Dimitriou & Despoina Gkentzi. (2022) Parental attitudes towards vaccination against COVID‐19 of children 5–11 years old in Greece. Journal of Evaluation in Clinical Practice 28:6, pages 943-947.
Crossref
Nathan Fox, Philip Adams, David Grainger, Jennifer Herz & Carolyn Austin. (2022) The Value of Vaccines: A Tale of Two Parts. Vaccines 10:12, pages 2057.
Crossref
Yaqun Fu, Jingyu Zhao, Xia Wei, Peien Han, Li Yang, Tao Ren, Siyan Zhan & Liming Li. (2022) Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China. Vaccines 10:10, pages 1712.
Crossref
V. M. Timiryanova, I. A. Lakman, N. Sh. Zagidullin & D. F. Gareeva. (2022) Economic burden of the novel coronavirus infection: a systematic review. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15:3, pages 363-379.
Crossref
Jung Eun Kim, Heejin Choi, Yongin Choi & Chang Hyeong Lee. (2022) The economic impact of COVID-19 interventions: A mathematical modeling approach. Frontiers in Public Health 10.
Crossref
Aaron Shengting Mai, Ainsley Ryan Yan Bin Lee, Ryan Yong Kiat Tay, Lauren Shapiro, Astha Thakkar, Balazs Halmos, Albert Grinshpun, Yair Herishanu, Ohad Benjamini, Tamar Tadmor, Rachna T. Shroff, Bonnie J. LaFleur, Deepta Bhattacharya, Siyu Peng, Jeremy Tey, Soo Chin Lee, Louis Yi Ann Chai, Yu Yang Soon, Raghav Sundar & Matilda Xinwei Lee. (2022) Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis. European Journal of Cancer 172, pages 65-75.
Crossref
Yaqun Fu, Jingyu Zhao, Xia Wei, Peien Han, Li Yang, Tao Ren, Siyan Zhan & Liming Li. (2022) Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies. Frontiers in Public Health 10.
Crossref
Louise Rawlings, Jeffrey C. L. Looi & Stephen J. Robson. (2022) Economic Considerations in COVID ‐19 Vaccine Hesitancy and Refusal: A Survey of the Literature* . Economic Record 98:321, pages 214-229.
Crossref
Xuechen Xiong, Jing Li, Bo Huang, Tony Tam, Yingyi Hong, Ka-Chun Chong & Zhaohua Huo. (2022) Economic Value of Vaccines to Address the COVID-19 Pandemic in Hong Kong: A Cost-Effectiveness Analysis. Vaccines 10:4, pages 495.
Crossref
Runyu Liu, Junbing Pan, Chunxiang Zhang & Xiaolei Sun. (2022) Cardiovascular Complications of COVID-19 Vaccines. Frontiers in Cardiovascular Medicine 9.
Crossref
Yimiao Gong, Xiaoxing Liu, Yongbo Zheng, Huan Mei, Jianyu Que, Kai Yuan, Wei Yan, Le Shi, Shiqiu Meng, Yanping Bao & Lin Lu. (2022) COVID-19 Induced Economic Slowdown and Mental Health Issues. Frontiers in Psychology 13.
Crossref
Giulia Zamagni, Benedetta Armocida, Cristiana Abbafati, Luca Ronfani & Lorenzo Monasta. (2022) COVID-19 Vaccination Coverage in Italy: How Many Hospitalisations and Related Costs Could Have Been Saved If We Were All Vaccinated?. Frontiers in Public Health 10.
Crossref
Francesc López, Martí Català, Clara Prats, Oriol Estrada, Irene Oliva, Núria Prat, Mar Isnard, Roser Vallès, Marc Vilar, Bonaventura Clotet, Josep Maria Argimon, Anna Aran & Jordi Ara. (2021) A Cost–Benefit Analysis of COVID-19 Vaccination in Catalonia. Vaccines 10:1, pages 59.
Crossref
Lihui Zhou, Wenxin Yan, Shu Li, Hongxi Yang, Xinyu Zhang, Wenli Lu, Jue Liu & Yaogang WANG. (2021) Cost-Effectiveness of Interventions for the Prevention and Control of COVID-19: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.